Literature DB >> 18665980

Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery.

Marc Muchow1, Philippe Maincent, Rainer H Muller.   

Abstract

Solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid-drug conjugates (LDC), commonly produced by high-pressure homogenization, are interesting vectors for oral delivery of lipophilic and, to a certain extent, hydrophilic substances. Their production can be done without the use of organic solvents. Techniques to make them a physically stable delivery system have been developed. Scaling up of the production process from lab-size to large-scale dimensions using high-pressure homogenization can be easily achieved by using a different type of homogenizer. The machines used for large-scale production often yield an even better product quality than the lab-scale types. This review article covers the methods of production, characterization, mechanisms of oral bioavailability enhancement, scale-up, final oral dosage forms, and regulatory aspects of lipid nanoparticles for oral drug delivery. It focuses mainly on high-pressure homogenization production methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18665980     DOI: 10.1080/03639040802130061

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  47 in total

Review 1.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

2.  Macrophage endocytic trafficking of antiretroviral nanoparticles.

Authors:  Irena Kadiu; Ari Nowacek; Joellyn McMillan; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2011-03-21       Impact factor: 5.307

3.  Multiple Lipid Nanoparticles (MLN), a New Generation of Lipid Nanoparticles for Drug Delivery Systems: Lamivudine-MLN Experimental Design.

Authors:  Suellen M T Cavalcanti; Cláudia Nunes; Sofia A C Lima; José L Soares-Sobrinho; Salette Reis
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

Review 4.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

Review 5.  The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review.

Authors:  Leila Azhar Shekoufeh Bahari; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-06-30

Review 6.  Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Authors:  Surajit Das; Anumita Chaudhury
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

7.  A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.

Authors:  B Karthik Grandhi; Arvind Thakkar; Jeffrey Wang; Sunil Prabhu
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-26

8.  Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol.

Authors:  Anna Elgart; Irina Cherniakov; Yanir Aldouby; Abraham J Domb; Amnon Hoffman
Journal:  Pharm Res       Date:  2013-05-18       Impact factor: 4.200

Review 9.  Nanoparticles for biomedical imaging.

Authors:  Satish K Nune; Padmaja Gunda; Praveen K Thallapally; Ying-Ying Lin; M Laird Forrest; Cory J Berkland
Journal:  Expert Opin Drug Deliv       Date:  2009-11       Impact factor: 6.648

Review 10.  Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.

Authors:  Neda Naseri; Hadi Valizadeh; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2015-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.